US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist

0.528
+0.088+20.00%

Close Jan 3 16:00 ET

0.540
+0.012+2.25%

Post 19:56 ET

22.05MMarket Cap-0.35P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Carisma Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 4.693M	--
--	2024/Q4	-- / 5.421M	--
--	2024/Q3	3.385M / 5.049M	--
--	2024/Q2	9.197M / 3.924M	--
--	2024/Q1	3.397M / 4.396M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 4.693M--

--2024/Q4-- / 5.421M--

--2024/Q33.385M / 5.049M--

--2024/Q29.197M / 3.924M--

--2024/Q13.397M / 4.396M--

Unlock Free Earnings Estimates

Open Account

Carisma Therapeutics Earnings Reports

Carisma Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 07:43 ET

Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 7, 2024 07:38 ET

Carisma Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 07:44 ET

Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 8, 2024 07:39 ET

Analyst Rating

Updated: Jan 3, 2025

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall